Compare WPC & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WPC | BAX |
|---|---|---|
| Founded | 1973 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7B | 9.4B |
| IPO Year | 1998 | N/A |
| Metric | WPC | BAX |
|---|---|---|
| Price | $66.46 | $18.60 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 10 |
| Target Price | ★ $112.50 | $25.67 |
| AVG Volume (30 Days) | 1.2M | ★ 8.3M |
| Earning Date | 10-28-2025 | 10-30-2025 |
| Dividend Yield | ★ 5.49% | 0.22% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | $1,670,291,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $7.52 | $5.20 |
| Revenue Next Year | $3.54 | $2.02 |
| P/E Ratio | $40.17 | ★ N/A |
| Revenue Growth | ★ 5.29 | 3.90 |
| 52 Week Low | $52.91 | $17.40 |
| 52 Week High | $69.79 | $37.74 |
| Indicator | WPC | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 43.20 |
| Support Level | $66.17 | $18.33 |
| Resistance Level | $67.07 | $19.17 |
| Average True Range (ATR) | 0.83 | 0.54 |
| MACD | -0.04 | 0.21 |
| Stochastic Oscillator | 18.56 | 63.23 |
W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.